Mergers & Acquisitions
Feds indict ex-Acclarent execs | The week in medtech M&A
U.S. regulators OK $1.4B Sorin-Cyberonics tie-up
Big data: IBM enlists Medtronic, J&J, Apple in major healthcare push
Zimmer extends deadline for $13B Biomet deal
Feds slap former Acclarent execs with fraud charges
Federal prosecutors last week leveled conspiracy and fraud charges against 2 former executives of Acclarent for an alleged off-label marketing scheme for the Relieva Stratus microflow spacer.
BSX pays $63m for Xlumena | The week in medtech M&A
Cogentix shifts Mass. manufacturing plant
Cogentix Medical (NSDQ:CGNT) said it plans to uproot a Massachusetts manufacturing facility and move it from Natick to nearby Westborough.
Integra LifeSciences readies SeaSpine spinout
Integra LifeSciences (NSDQ:IART) is gearing up for the spinout of its spinal implant business, SeaSpine, which is slated for the 2nd half of 2015.